Home Cart 0 Sign in  
X

[ CAS No. 10470-83-4 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 10470-83-4
Chemical Structure| 10470-83-4
Chemical Structure| 10470-83-4
Structure of 10470-83-4 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 10470-83-4 ]

Related Doc. of [ 10470-83-4 ]

Alternatived Products of [ 10470-83-4 ]

Product Details of [ 10470-83-4 ]

CAS No. :10470-83-4 MDL No. :MFCD04038780
Formula : C9H5NO2 Boiling Point : -
Linear Structure Formula :- InChI Key :NVJSPQCVDHGYRE-UHFFFAOYSA-N
M.W : 159.14 Pubchem ID :388306
Synonyms :

Calculated chemistry of [ 10470-83-4 ]

Physicochemical Properties

Num. heavy atoms : 12
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.0
Num. rotatable bonds : 0
Num. H-bond acceptors : 3.0
Num. H-bond donors : 0.0
Molar Refractivity : 42.04
TPSA : 47.03 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.77 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.87
Log Po/w (XLOGP3) : 0.71
Log Po/w (WLOGP) : 1.02
Log Po/w (MLOGP) : -0.27
Log Po/w (SILICOS-IT) : 1.76
Consensus Log Po/w : 0.82

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.64
Solubility : 3.61 mg/ml ; 0.0227 mol/l
Class : Very soluble
Log S (Ali) : -1.28
Solubility : 8.44 mg/ml ; 0.053 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.43
Solubility : 0.59 mg/ml ; 0.00371 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 1.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.29

Safety of [ 10470-83-4 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P280-P301+P312-P302+P352-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H320-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 10470-83-4 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 10470-83-4 ]
  • Downstream synthetic route of [ 10470-83-4 ]

[ 10470-83-4 ] Synthesis Path-Upstream   1~15

  • 1
  • [ 91-22-5 ]
  • [ 148-24-3 ]
  • [ 578-67-6 ]
  • [ 10470-83-4 ]
  • [ 59-31-4 ]
  • [ 529-37-3 ]
  • [ 529-23-7 ]
Reference: [1] Journal of Physical Chemistry B, 1997, vol. 101, # 14, p. 2650 - 2658
  • 2
  • [ 578-67-6 ]
  • [ 10470-83-4 ]
YieldReaction ConditionsOperation in experiment
82% With [bis(acetoxy)iodo]benzene In water; acetonitrile at 0℃; for 1 h; Inert atmosphere A solution of iodobenzene diacetate (10.35mmol, 3.3g) in 12mL CH3CN: H2O (2:1) was added to quinolin-5-ol (3) (3.45mmol, 0.50g) at 0°C under N2 and stirred for 1h. After the reaction was completed, water (40mL) was added, and the solution was extracted with EtOAc (3×20mL). The organic phase was washed by brine and concentrated in vacuo to give 4 as a yellow solid, yield 82percent. MS (ESI) m/z = 160 [M+H]+.
Reference: [1] Tetrahedron Letters, 1990, vol. 31, # 34, p. 4871 - 4872
[2] Organic and Biomolecular Chemistry, 2011, vol. 9, # 13, p. 4959 - 4976
[3] European Journal of Medicinal Chemistry, 2018, vol. 154, p. 199 - 209
[4] Synthetic Communications, 1999, vol. 29, # 18, p. 3063 - 3066
  • 3
  • [ 13207-66-4 ]
  • [ 10470-83-4 ]
YieldReaction ConditionsOperation in experiment
61% With sodium dichromate; sulfuric acid In dichloromethane; water at 0℃; for 1 h; To 0.80g (5.0mmol) of 5-amino-8-hydroxyquinoline in 150mL of CH2Cl2 at 0°C was added 150mL of a 5percent aqueous solution of H2SO4 followed by slow addition of a pre-cooled solution of 2.98g (10.0mmol) of sodium dichromate in 50mL of H2O at 0°C. The yellow solution became orange and biphasic. After 1h, the reaction was extracted with methylene chloride and washed with brine. The organic extract was dried over magnesium sulfate and filtered. The solvent was removed under reduced pressure to give a yellow solid. The solid was purified using silica gel column chromatography eluting 3:2 ethyl acetate–hexanes to afford 0.49g (61percent) of quinoline-5,8-dione. 1H NMR (400MHz, CDCl3) δ: 8.90 (d, J=4.6Hz, 1H), 8.71 (s, 1H), 8.41 (d, J=8.1Hz, 1H), 7.74 (dd, J=4.6, 8.1Hz, 1H), 7.06 (d, J=10.9Hz, 1H), 6.90 (d, J=10.9Hz, 1H). 13C NMR (100.17MHz, CDCl3) δ: 182.1, 180.7, 148.8, 147.2, 138.2, 138.1, 135.4, 129.0, 128.3.
Reference: [1] Bioorganic and Medicinal Chemistry, 2014, vol. 22, # 1, p. 478 - 487
[2] Patent: US4492704, 1985, A,
[3] Chemische Berichte, 1884, vol. 17, p. 1645
  • 4
  • [ 58868-41-0 ]
  • [ 10470-83-4 ]
Reference: [1] Chemical and Pharmaceutical Bulletin, 1983, vol. 31, # 1, p. 341 - 343
[2] Bioorganic and Medicinal Chemistry Letters, 2010, vol. 20, # 13, p. 3950 - 3952
[3] Patent: KR2015/80425, 2015, A, . Location in patent: Paragraph 0450-0453
  • 5
  • [ 148-24-3 ]
  • [ 10470-83-4 ]
YieldReaction ConditionsOperation in experiment
44% With potassium dihydrogenphosphate; Fremy's salt In water; acetone at 20℃; for 3.16667 h; Example 2.1: Procedure for the Preparation of the Starting Materials; Typically a solution of Fremy's salt (1 g, 4 mmol) and potassium dihydrogenphosphate (400 mg, 3 mmol) in water (75 ml) was stirred at room temperature for 10 min then the quinolinol (6 mmol) in acetone (70 ml) was added. The mixture was stirred for 30 min, then a further solution of Fremy's salt (1 g) and potassium dihydrogenphosphate (400 mg) in water (30 ml) was added and the mixture stirred for 30 min, then a further solution of Fremy's salt (1 g) and potassium dihydrogenphosphate (400 mg) in water (30 ml) was added and the mixture stirred for a further 2 h. The mixture was extracted into dichloromethane, dried and evaporated in vacuo to give the product as an orange gum. Purification by column chromatography over silica gel eluting with ethyl acetate (0 - 40percent ) in dichloromethane gave the products as orange solids.The following quinolines were prepared using this method; 5,8-Dihydro-5,8-dioxoquinoline (reg. no. 858471-89-3); 8-Hydroxyquinoline (1 g, 7 mmol) to give quinone (0.48 g, 44percent).
Reference: [1] Australian Journal of Chemistry, 1982, vol. 35, # 7, p. 1439 - 1450
[2] Organic and Biomolecular Chemistry, 2008, vol. 6, # 15, p. 2731 - 2742
[3] Tetrahedron Letters, 2001, vol. 42, # 26, p. 4329 - 4331
[4] Synthetic Communications, 1999, vol. 29, # 18, p. 3063 - 3066
[5] Patent: WO2006/31134, 2006, A1, . Location in patent: Page/Page column 18-19
[6] Bioorganic and Medicinal Chemistry, 2008, vol. 16, # 21, p. 9432 - 9442
[7] Polish Journal of Chemistry, 1998, vol. 72, # 1, p. 122 - 126
[8] Chemische Berichte, 1954, vol. 87, p. 1236,1250
[9] Journal of Heterocyclic Chemistry, 2002, vol. 39, # 1, p. 125 - 130
[10] Zeitschrift fuer Naturforschung, B: Chemical Sciences, 1991, vol. 46, # 3, p. 326 - 338
[11] Journal of the Chemical Society, 1953, p. 3161,3166
[12] Tetrahedron Letters, 2013, vol. 54, # 24, p. 3147 - 3149
[13] Bioorganic and Medicinal Chemistry, 2014, vol. 22, # 17, p. 4609 - 4620
  • 6
  • [ 578-67-6 ]
  • [ 10470-83-4 ]
Reference: [1] Patent: US4692449, 1987, A,
  • 7
  • [ 578-66-5 ]
  • [ 10470-83-4 ]
Reference: [1] Tetrahedron Letters, 1990, vol. 31, # 34, p. 4871 - 4872
[2] Tetrahedron Letters, 1990, vol. 31, # 34, p. 4871 - 4872
  • 8
  • [ 611-34-7 ]
  • [ 10470-83-4 ]
Reference: [1] Tetrahedron Letters, 1990, vol. 31, # 34, p. 4871 - 4872
[2] Tetrahedron Letters, 1990, vol. 31, # 34, p. 4871 - 4872
  • 9
  • [ 63450-86-2 ]
  • [ 10470-83-4 ]
Reference: [1] Journal of Heterocyclic Chemistry, 2002, vol. 39, # 1, p. 125 - 130
[2] Zeitschrift fuer Naturforschung, B: Chemical Sciences, 1991, vol. 46, # 3, p. 326 - 338
  • 10
  • [ 75-91-2 ]
  • [ 148-24-3 ]
  • [ 10470-83-4 ]
  • [ 75-65-0 ]
Reference: [1] Green Chemistry, 2010, vol. 12, # 6, p. 1076 - 1082
  • 11
  • [ 75-91-2 ]
  • [ 148-24-3 ]
  • [ 10470-83-4 ]
  • [ 84288-96-0 ]
  • [ 75-65-0 ]
Reference: [1] Green Chemistry, 2010, vol. 12, # 6, p. 1076 - 1082
  • 12
  • [ 30465-68-0 ]
  • [ 10470-83-4 ]
Reference: [1] Angewandte Chemie - International Edition, 2013, vol. 52, # 42, p. 11124 - 11128[2] Angew. Chem., 2013, vol. 125, # 42, p. 11330 - 11334,5
[3] Angewandte Chemie - International Edition, 2013, vol. 52, # 42, p. 11124 - 11128[4] Angew. Chem., 2013, vol. 125, # 42, p. 11330 - 11334,5
  • 13
  • [ 4008-48-4 ]
  • [ 10470-83-4 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2014, vol. 22, # 1, p. 478 - 487
  • 14
  • [ 574-70-9 ]
  • [ 10470-83-4 ]
Reference: [1] Journal of the Chemical Society, 1953, p. 3161,3166
  • 15
  • [ 91-22-5 ]
  • [ 148-24-3 ]
  • [ 578-67-6 ]
  • [ 10470-83-4 ]
  • [ 59-31-4 ]
  • [ 529-37-3 ]
  • [ 529-23-7 ]
Reference: [1] Journal of Physical Chemistry B, 1997, vol. 101, # 14, p. 2650 - 2658
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 10470-83-4 ]

Ketones

Chemical Structure| 53400-41-2

[ 53400-41-2 ]

7,8-Dihydroquinolin-5(6H)-one

Similarity: 0.85

Chemical Structure| 56234-20-9

[ 56234-20-9 ]

1-(Quinolin-8-yl)ethanone

Similarity: 0.84

Chemical Structure| 56826-69-8

[ 56826-69-8 ]

6,7-Dihydro-5H-quinoline-8-one

Similarity: 0.84

Chemical Structure| 1122-62-9

[ 1122-62-9 ]

1-(Pyridin-2-yl)ethanone

Similarity: 0.76

Chemical Structure| 6541-19-1

[ 6541-19-1 ]

6,7-Dichloroquinoline-5,8-dione

Similarity: 0.75

Related Parent Nucleus of
[ 10470-83-4 ]

Quinolines

Chemical Structure| 56234-20-9

[ 56234-20-9 ]

1-(Quinolin-8-yl)ethanone

Similarity: 0.84

Chemical Structure| 6541-19-1

[ 6541-19-1 ]

6,7-Dichloroquinoline-5,8-dione

Similarity: 0.75

Chemical Structure| 38707-70-9

[ 38707-70-9 ]

Quinoline-8-carbaldehyde

Similarity: 0.75

Chemical Structure| 22934-41-4

[ 22934-41-4 ]

Quinoline-5-carbaldehyde

Similarity: 0.75

Chemical Structure| 108166-03-6

[ 108166-03-6 ]

2-Methylquinoline-6-carbaldehyde

Similarity: 0.69